A. Zimmermann

发表

The posterior distribution of the fixed and random effects in a mixed-effects linear model

Alan G. Zimmermann, David A. Harville, D. Harville, 1996 .

Inference about the fixed and random effects in a mixed-effects linear model: an approximate Bayesian approach

A. Zimmermann, 1993 .

Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes.

C. Deal, C. Quigley, W. Blum, 2016, European journal of endocrinology.

Associations between Pituitary Imaging Abnormalities and Clinical and Biochemical Phenotypes in Children with Congenital Growth Hormone Deficiency: Data from an International Observational Study

C. Deal, C. Quigley, W. Blum, 2013, Hormone Research in Paediatrics.

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.

K. Tuttle, R. Busch, M. Lakshmanan, 2018, The lancet. Diabetes & endocrinology.

Relationship between weight change and glycaemic control in patients with type 2 diabetes receiving once‐weekly dulaglutide treatment

G. Umpierrez, K. Pantalone, A. Zimmermann, 2016, Diabetes, obesity & metabolism.

Radiological Features in Patients with Short Stature Homeobox-Containing (SHOX) Gene Deficiency and Turner Syndrome before and after 2 Years of GH Treatment

G. Rappold, J. Ross, C. Quigley, 2015, Hormone Research in Paediatrics.

in Pediatric Patients Originally Diagnosed with Idiopathic

C. Deal, C. Quigley, W. Blum, 2013 .

GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.

G. Rappold, C. Deal, J. Ross, 2013, The Journal of clinical endocrinology and metabolism.

Preliminary studies on the effectiveness of the novel pulicide, spinosad, for the treatment and control of fleas on dogs.

D. Snyder, A. Zimmermann, Meihua Qiao, 2007, Veterinary parasitology.

Effects of tilmicosin on acute undifferentiated respiratory tract disease in newly arrived feedlot cattle.

A. Zimmermann, S. Laudert, G. Mechor, 1998, Journal of the American Veterinary Medical Association.

Randomized, controlled clinical trial of the efficacy of fluoxetine for treatment of compulsive disorders in dogs.

A. Zimmermann, R. Hozak, M. Irimajiri, 2009, Journal of the American Veterinary Medical Association.

Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.

P. Chanson, D. Kleinberg, E. Erfurth, 2011, The Journal of clinical endocrinology and metabolism.

Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes

S. Amselem, C. Deal, J. Parks, 2018, EBioMedicine.

Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research program.

T. Battelino, W. Blum, A. Zimmermann, 2011, The Journal of clinical endocrinology and metabolism.

Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program

M. Maghnie, G. Chrousos, M. Polak, 2018, The Journal of clinical endocrinology and metabolism.

Assessment of Primary Cancer Incidence in Growth Hormone-Treated Children: Comparison of a Multinational Prospective Observational Study with Population Databases

L. Robison, W. Blum, A. Zimmermann, 2016, Hormone Research in Paediatrics.

Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study.

L. Robison, W. Woodmansee, E. Erfurth, 2015, European journal of endocrinology.

Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.

L. Robison, W. Woodmansee, P. Beck‐Peccoz, 2013, European journal of endocrinology.

Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study

D. Green, L. Robison, W. Woodmansee, 2011, European journal of endocrinology.

Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients

Brenda J. Crowe, L. Robison, S. Melmed, 2013, The Journal of clinical endocrinology and metabolism.

Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency.

C. Deal, C. Quigley, W. Blum, 2014, European journal of endocrinology.

Mortality in Children Receiving Growth Hormone Treatment of Growth Disorders: Data From the Genetics and Neuroendocrinology of Short Stature International Study

L. Robison, C. Quigley, W. Blum, 2017, The Journal of clinical endocrinology and metabolism.

Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma.

S. Melmed, W. Woodmansee, S. Lamberts, 2010, The Journal of clinical endocrinology and metabolism.

Efficacy of different dosage levels and administration routes of tilmicosin in a natural outbreak of infectious bovine keratoconjunctivitis (pinkeye).

A. Zimmermann, H. Perez-Monti, G. Zielinski, 2002, Veterinary therapeutics : research in applied veterinary medicine.

Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7)

K. Tuttle, M. Lakshmanan, A. Zimmermann, 2019, Diabetes, obesity & metabolism.

Effects of orally administered spinosad (Comfortis) in dogs on adult and immature stages of the cat flea (Ctenocephalides felis).

B. Blagburn, S. Wiseman, D. Snyder, 2010, Veterinary parasitology.

Clinical field study of the safety and efficacy of spinosad chewable tablets for controlling fleas on dogs.

D. Snyder, A. Zimmermann, R. Hozak, 2008, Veterinary therapeutics : research in applied veterinary medicine.

Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)

F. Giorgino, V. Pechtner, A. Zimmermann, 2015, Diabetes Care.

Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial

C. Deal, J. Ross, C. Quigley, 2016, Hormone Research in Paediatrics.

A COMPARISON OF MULTIPLE TESTING METHODS: SPINOSAD AS A TREATMENT FOR LICE ON CATTLE

A. Zimmermann, D. Mowrey, Z. Cui, 2006 .

Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes

Debra A Ignaut, G. Matfin, A. Zimmermann, 2015, Journal of diabetes science and technology.